Atomistry » Fluorine » PDB 4f9w-4fvx » 4f9w
Atomistry »
  Fluorine »
    PDB 4f9w-4fvx »
      4f9w »

Fluorine in PDB 4f9w: Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor

Enzymatic activity of Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor

All present enzymatic activity of Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor:
2.7.11.24;

Protein crystallography data

The structure of Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor, PDB code: 4f9w was solved by V.L.Grum-Tokars, G.Minasov, W.F.Anderson, D.M.Watterson, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.80 / 2.00
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 65.671, 74.311, 77.270, 90.00, 90.00, 90.00
R / Rfree (%) 17.1 / 21.6

Other elements in 4f9w:

The structure of Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor also contains other interesting chemical elements:

Zinc (Zn) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor (pdb code 4f9w). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor, PDB code: 4f9w:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 4f9w

Go back to Fluorine Binding Sites List in 4f9w
Fluorine binding site 1 out of 2 in the Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F401

b:36.2
occ:1.00
F19 A:GG5401 0.0 36.2 1.0
C16 A:GG5401 1.3 34.6 1.0
C17 A:GG5401 2.3 30.9 1.0
C15 A:GG5401 2.4 30.6 1.0
CD1 A:ILE259 3.5 46.0 1.0
CG A:PRO242 3.5 40.6 1.0
C18 A:GG5401 3.6 30.2 1.0
C14 A:GG5401 3.6 32.1 1.0
CD1 A:LEU195 3.6 37.9 1.0
CG1 A:ILE259 3.9 47.9 1.0
CD A:PRO242 4.0 39.4 1.0
CD2 A:LEU236 4.0 30.9 1.0
C13 A:GG5401 4.1 28.0 1.0
CD1 A:LEU236 4.2 33.8 1.0
CD1 A:LEU232 4.3 36.3 1.0
CG2 A:ILE259 4.4 45.6 1.0
CD2 A:LEU291 4.5 40.9 1.0
CD2 A:LEU232 4.6 37.0 1.0
CG A:LEU236 4.7 32.5 1.0
CB A:PRO242 4.7 39.1 1.0
CB A:ILE259 4.8 47.3 1.0
CG A:LEU232 4.9 35.4 1.0
CG A:LEU195 4.9 38.3 1.0
CG A:LEU291 5.0 38.3 1.0

Fluorine binding site 2 out of 2 in 4f9w

Go back to Fluorine Binding Sites List in 4f9w
Fluorine binding site 2 out of 2 in the Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human P38ALPHA Mapk in Complex with A Novel and Selective Small Molecule Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F402

b:85.9
occ:1.00
F19 A:GG5402 0.0 85.9 1.0
C16 A:GG5402 1.3 67.0 1.0
C17 A:GG5402 2.4 66.6 1.0
C15 A:GG5402 2.4 59.3 1.0
C18 A:GG5402 3.6 65.1 1.0
C14 A:GG5402 3.7 54.8 1.0
CE1 A:TYR258 4.0 55.1 1.0
CD1 A:TYR258 4.2 54.4 1.0
C13 A:GG5402 4.2 59.0 1.0
O A:HOH623 4.8 63.3 1.0

Reference:

D.M.Watterson, V.L.Grum-Tokars, S.M.Roy, J.P.Schavocky, B.D.Bradaric, A.D.Bachstetter, B.Xing, E.Dimayuga, F.Saeed, H.Zhang, A.Staniszewski, J.C.Pelletier, G.Minasov, W.F.Anderson, O.Arancio, L.J.Van Eldik. Development of Novel in Vivo Chemical Probes to Address Cns Protein Kinase Involvement in Synaptic Dysfunction. Plos One V. 8 66226 2013.
ISSN: ESSN 1932-6203
PubMed: 23840427
DOI: 10.1371/JOURNAL.PONE.0066226
Page generated: Sun Dec 13 12:02:24 2020

Last articles

Zn in 7VD8
Zn in 7V1R
Zn in 7V1Q
Zn in 7VPF
Zn in 7T85
Zn in 7T5F
Zn in 7NF9
Zn in 7M4M
Zn in 7M4O
Zn in 7M4N
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy